Rodent models of hypertension

Elevated blood pressure (BP), or hypertension, is the main risk factor for cardiovascular disease. As a multifactorial and systemic disease that involves multiple organs and systems, hypertension remains a challenging disease to study. Models of hypertension are invaluable to support the discovery o...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:British journal of pharmacology 2022-03, Vol.179 (5), p.918-937
Hauptverfasser: Jama, Hamdi A., Muralitharan, Rikeish R., Xu, Chudan, O'Donnell, Joanne A., Bertagnolli, Mariane, Broughton, Bradley R. S., Head, Geoffrey A., Marques, Francine Z.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 937
container_issue 5
container_start_page 918
container_title British journal of pharmacology
container_volume 179
creator Jama, Hamdi A.
Muralitharan, Rikeish R.
Xu, Chudan
O'Donnell, Joanne A.
Bertagnolli, Mariane
Broughton, Bradley R. S.
Head, Geoffrey A.
Marques, Francine Z.
description Elevated blood pressure (BP), or hypertension, is the main risk factor for cardiovascular disease. As a multifactorial and systemic disease that involves multiple organs and systems, hypertension remains a challenging disease to study. Models of hypertension are invaluable to support the discovery of the specific genetic, cellular and molecular mechanisms underlying essential hypertension, as well as to test new possible treatments to lower BP. Rodent models have proven to be an invaluable tool for advancing the field. In this review, we discuss the strengths and weaknesses of rodent models of hypertension through a systems approach. We highlight the ways how target organs and systems including the kidneys, vasculature, the sympathetic nervous system (SNS), immune system and the gut microbiota influence BP in each rodent model. We also discuss often overlooked hypertensive conditions such as pulmonary hypertension and hypertensive‐pregnancy disorders, providing an important resource for researchers. LINKED ARTICLES This article is part of a themed issue on Preclinical Models for Cardiovascular disease research (BJP 75th Anniversary). To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v179.5/issuetoc
doi_str_mv 10.1111/bph.15650
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2559427999</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2559427999</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3880-45a79d917bffd3d07308de8e858315d68fe939629c328409058957914b2a66f33</originalsourceid><addsrcrecordid>eNp1kE1Lw0AQQBdRbK0e_AFKwYse0u7sZr-OWvyCgiJ6XpLsLk1JsjHbIP33rqZ6EJzLHObxGB5Cp4BnEGeet6sZMM7wHhpDKnjCqIR9NMYYiwRAyhE6CmGNcTwKdohGNKWccsBjdPbijW020zquKky9m662re02tgmlb47RgcuqYE92e4Le7m5fFw_J8un-cXG9TAoqJU5SlgllFIjcOUMNFhRLY6WVTFJghktnFVWcqIISmWKFmVRMKEhzknHuKJ2gy8Hbdv69t2Gj6zIUtqqyxvo-aMKYSolQSkX04g-69n3XxO804UQA4YJDpK4Gquh8CJ11uu3KOuu2GrD-aqZjM_3dLLLnO2Of19b8kj-RIjAfgI-ystv_Tfrm-WFQfgLZS3F8</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2627126761</pqid></control><display><type>article</type><title>Rodent models of hypertension</title><source>Wiley Online Library - AutoHoldings Journals</source><source>MEDLINE</source><source>EZB-FREE-00999 freely available EZB journals</source><source>Wiley Online Library (Open Access Collection)</source><source>Alma/SFX Local Collection</source><creator>Jama, Hamdi A. ; Muralitharan, Rikeish R. ; Xu, Chudan ; O'Donnell, Joanne A. ; Bertagnolli, Mariane ; Broughton, Bradley R. S. ; Head, Geoffrey A. ; Marques, Francine Z.</creator><creatorcontrib>Jama, Hamdi A. ; Muralitharan, Rikeish R. ; Xu, Chudan ; O'Donnell, Joanne A. ; Bertagnolli, Mariane ; Broughton, Bradley R. S. ; Head, Geoffrey A. ; Marques, Francine Z.</creatorcontrib><description>Elevated blood pressure (BP), or hypertension, is the main risk factor for cardiovascular disease. As a multifactorial and systemic disease that involves multiple organs and systems, hypertension remains a challenging disease to study. Models of hypertension are invaluable to support the discovery of the specific genetic, cellular and molecular mechanisms underlying essential hypertension, as well as to test new possible treatments to lower BP. Rodent models have proven to be an invaluable tool for advancing the field. In this review, we discuss the strengths and weaknesses of rodent models of hypertension through a systems approach. We highlight the ways how target organs and systems including the kidneys, vasculature, the sympathetic nervous system (SNS), immune system and the gut microbiota influence BP in each rodent model. We also discuss often overlooked hypertensive conditions such as pulmonary hypertension and hypertensive‐pregnancy disorders, providing an important resource for researchers. LINKED ARTICLES This article is part of a themed issue on Preclinical Models for Cardiovascular disease research (BJP 75th Anniversary). To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v179.5/issuetoc</description><identifier>ISSN: 0007-1188</identifier><identifier>EISSN: 1476-5381</identifier><identifier>DOI: 10.1111/bph.15650</identifier><identifier>PMID: 34363610</identifier><language>eng</language><publisher>England: Blackwell Publishing Ltd</publisher><subject>Ang II ; Animal models ; Animals ; Blood pressure ; Cardiovascular disease ; Cardiovascular Diseases ; DOCA ; Female ; Hypertension ; Immune system ; Inflammation ; Intestinal microflora ; Kidneys ; microbiome ; Microbiota ; Molecular modelling ; Pregnancy ; Risk factors ; Rodentia ; salt ; SHR ; Sympathetic Nervous System</subject><ispartof>British journal of pharmacology, 2022-03, Vol.179 (5), p.918-937</ispartof><rights>2021 The British Pharmacological Society</rights><rights>2021 The British Pharmacological Society.</rights><rights>2022 The British Pharmacological Society</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3880-45a79d917bffd3d07308de8e858315d68fe939629c328409058957914b2a66f33</citedby><cites>FETCH-LOGICAL-c3880-45a79d917bffd3d07308de8e858315d68fe939629c328409058957914b2a66f33</cites><orcidid>0000-0002-1093-1445 ; 0000-0002-7577-2123 ; 0000-0002-7623-137X ; 0000-0002-8434-1050 ; 0000-0003-4920-9991</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fbph.15650$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fbph.15650$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,780,784,1417,1433,27924,27925,45574,45575,46409,46833</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34363610$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Jama, Hamdi A.</creatorcontrib><creatorcontrib>Muralitharan, Rikeish R.</creatorcontrib><creatorcontrib>Xu, Chudan</creatorcontrib><creatorcontrib>O'Donnell, Joanne A.</creatorcontrib><creatorcontrib>Bertagnolli, Mariane</creatorcontrib><creatorcontrib>Broughton, Bradley R. S.</creatorcontrib><creatorcontrib>Head, Geoffrey A.</creatorcontrib><creatorcontrib>Marques, Francine Z.</creatorcontrib><title>Rodent models of hypertension</title><title>British journal of pharmacology</title><addtitle>Br J Pharmacol</addtitle><description>Elevated blood pressure (BP), or hypertension, is the main risk factor for cardiovascular disease. As a multifactorial and systemic disease that involves multiple organs and systems, hypertension remains a challenging disease to study. Models of hypertension are invaluable to support the discovery of the specific genetic, cellular and molecular mechanisms underlying essential hypertension, as well as to test new possible treatments to lower BP. Rodent models have proven to be an invaluable tool for advancing the field. In this review, we discuss the strengths and weaknesses of rodent models of hypertension through a systems approach. We highlight the ways how target organs and systems including the kidneys, vasculature, the sympathetic nervous system (SNS), immune system and the gut microbiota influence BP in each rodent model. We also discuss often overlooked hypertensive conditions such as pulmonary hypertension and hypertensive‐pregnancy disorders, providing an important resource for researchers. LINKED ARTICLES This article is part of a themed issue on Preclinical Models for Cardiovascular disease research (BJP 75th Anniversary). To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v179.5/issuetoc</description><subject>Ang II</subject><subject>Animal models</subject><subject>Animals</subject><subject>Blood pressure</subject><subject>Cardiovascular disease</subject><subject>Cardiovascular Diseases</subject><subject>DOCA</subject><subject>Female</subject><subject>Hypertension</subject><subject>Immune system</subject><subject>Inflammation</subject><subject>Intestinal microflora</subject><subject>Kidneys</subject><subject>microbiome</subject><subject>Microbiota</subject><subject>Molecular modelling</subject><subject>Pregnancy</subject><subject>Risk factors</subject><subject>Rodentia</subject><subject>salt</subject><subject>SHR</subject><subject>Sympathetic Nervous System</subject><issn>0007-1188</issn><issn>1476-5381</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kE1Lw0AQQBdRbK0e_AFKwYse0u7sZr-OWvyCgiJ6XpLsLk1JsjHbIP33rqZ6EJzLHObxGB5Cp4BnEGeet6sZMM7wHhpDKnjCqIR9NMYYiwRAyhE6CmGNcTwKdohGNKWccsBjdPbijW020zquKky9m662re02tgmlb47RgcuqYE92e4Le7m5fFw_J8un-cXG9TAoqJU5SlgllFIjcOUMNFhRLY6WVTFJghktnFVWcqIISmWKFmVRMKEhzknHuKJ2gy8Hbdv69t2Gj6zIUtqqyxvo-aMKYSolQSkX04g-69n3XxO804UQA4YJDpK4Gquh8CJ11uu3KOuu2GrD-aqZjM_3dLLLnO2Of19b8kj-RIjAfgI-ystv_Tfrm-WFQfgLZS3F8</recordid><startdate>202203</startdate><enddate>202203</enddate><creator>Jama, Hamdi A.</creator><creator>Muralitharan, Rikeish R.</creator><creator>Xu, Chudan</creator><creator>O'Donnell, Joanne A.</creator><creator>Bertagnolli, Mariane</creator><creator>Broughton, Bradley R. S.</creator><creator>Head, Geoffrey A.</creator><creator>Marques, Francine Z.</creator><general>Blackwell Publishing Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QP</scope><scope>7TK</scope><scope>K9.</scope><scope>NAPCQ</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-1093-1445</orcidid><orcidid>https://orcid.org/0000-0002-7577-2123</orcidid><orcidid>https://orcid.org/0000-0002-7623-137X</orcidid><orcidid>https://orcid.org/0000-0002-8434-1050</orcidid><orcidid>https://orcid.org/0000-0003-4920-9991</orcidid></search><sort><creationdate>202203</creationdate><title>Rodent models of hypertension</title><author>Jama, Hamdi A. ; Muralitharan, Rikeish R. ; Xu, Chudan ; O'Donnell, Joanne A. ; Bertagnolli, Mariane ; Broughton, Bradley R. S. ; Head, Geoffrey A. ; Marques, Francine Z.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3880-45a79d917bffd3d07308de8e858315d68fe939629c328409058957914b2a66f33</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Ang II</topic><topic>Animal models</topic><topic>Animals</topic><topic>Blood pressure</topic><topic>Cardiovascular disease</topic><topic>Cardiovascular Diseases</topic><topic>DOCA</topic><topic>Female</topic><topic>Hypertension</topic><topic>Immune system</topic><topic>Inflammation</topic><topic>Intestinal microflora</topic><topic>Kidneys</topic><topic>microbiome</topic><topic>Microbiota</topic><topic>Molecular modelling</topic><topic>Pregnancy</topic><topic>Risk factors</topic><topic>Rodentia</topic><topic>salt</topic><topic>SHR</topic><topic>Sympathetic Nervous System</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Jama, Hamdi A.</creatorcontrib><creatorcontrib>Muralitharan, Rikeish R.</creatorcontrib><creatorcontrib>Xu, Chudan</creatorcontrib><creatorcontrib>O'Donnell, Joanne A.</creatorcontrib><creatorcontrib>Bertagnolli, Mariane</creatorcontrib><creatorcontrib>Broughton, Bradley R. S.</creatorcontrib><creatorcontrib>Head, Geoffrey A.</creatorcontrib><creatorcontrib>Marques, Francine Z.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>MEDLINE - Academic</collection><jtitle>British journal of pharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Jama, Hamdi A.</au><au>Muralitharan, Rikeish R.</au><au>Xu, Chudan</au><au>O'Donnell, Joanne A.</au><au>Bertagnolli, Mariane</au><au>Broughton, Bradley R. S.</au><au>Head, Geoffrey A.</au><au>Marques, Francine Z.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Rodent models of hypertension</atitle><jtitle>British journal of pharmacology</jtitle><addtitle>Br J Pharmacol</addtitle><date>2022-03</date><risdate>2022</risdate><volume>179</volume><issue>5</issue><spage>918</spage><epage>937</epage><pages>918-937</pages><issn>0007-1188</issn><eissn>1476-5381</eissn><abstract>Elevated blood pressure (BP), or hypertension, is the main risk factor for cardiovascular disease. As a multifactorial and systemic disease that involves multiple organs and systems, hypertension remains a challenging disease to study. Models of hypertension are invaluable to support the discovery of the specific genetic, cellular and molecular mechanisms underlying essential hypertension, as well as to test new possible treatments to lower BP. Rodent models have proven to be an invaluable tool for advancing the field. In this review, we discuss the strengths and weaknesses of rodent models of hypertension through a systems approach. We highlight the ways how target organs and systems including the kidneys, vasculature, the sympathetic nervous system (SNS), immune system and the gut microbiota influence BP in each rodent model. We also discuss often overlooked hypertensive conditions such as pulmonary hypertension and hypertensive‐pregnancy disorders, providing an important resource for researchers. LINKED ARTICLES This article is part of a themed issue on Preclinical Models for Cardiovascular disease research (BJP 75th Anniversary). To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v179.5/issuetoc</abstract><cop>England</cop><pub>Blackwell Publishing Ltd</pub><pmid>34363610</pmid><doi>10.1111/bph.15650</doi><tpages>20</tpages><orcidid>https://orcid.org/0000-0002-1093-1445</orcidid><orcidid>https://orcid.org/0000-0002-7577-2123</orcidid><orcidid>https://orcid.org/0000-0002-7623-137X</orcidid><orcidid>https://orcid.org/0000-0002-8434-1050</orcidid><orcidid>https://orcid.org/0000-0003-4920-9991</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0007-1188
ispartof British journal of pharmacology, 2022-03, Vol.179 (5), p.918-937
issn 0007-1188
1476-5381
language eng
recordid cdi_proquest_miscellaneous_2559427999
source Wiley Online Library - AutoHoldings Journals; MEDLINE; EZB-FREE-00999 freely available EZB journals; Wiley Online Library (Open Access Collection); Alma/SFX Local Collection
subjects Ang II
Animal models
Animals
Blood pressure
Cardiovascular disease
Cardiovascular Diseases
DOCA
Female
Hypertension
Immune system
Inflammation
Intestinal microflora
Kidneys
microbiome
Microbiota
Molecular modelling
Pregnancy
Risk factors
Rodentia
salt
SHR
Sympathetic Nervous System
title Rodent models of hypertension
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-24T13%3A32%3A50IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Rodent%20models%20of%20hypertension&rft.jtitle=British%20journal%20of%20pharmacology&rft.au=Jama,%20Hamdi%20A.&rft.date=2022-03&rft.volume=179&rft.issue=5&rft.spage=918&rft.epage=937&rft.pages=918-937&rft.issn=0007-1188&rft.eissn=1476-5381&rft_id=info:doi/10.1111/bph.15650&rft_dat=%3Cproquest_cross%3E2559427999%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2627126761&rft_id=info:pmid/34363610&rfr_iscdi=true